33 results on '"Busse W"'
Search Results
2. High-dose House Dust Mite (HDM) Sublingual Immunotherapy (SLIT) Increases Antigen-Specific Serum IgG 4 and PD 20 to HDM Antigen
Catalog
Books, media, physical & digital resources
3. Safety of Sublingual House Dust Mite (HDM) Immunotherapy: A Randomized, Double-blind, Placebo-controlled U.S. Trial
4. Comparative Safety and Efficacy of Fluticasone Propionate plus Salmeterol via Diskus® Versus Fluticasone Propionate in Subjects with Asthma Greater than or Equal to 55 and 65 Years of Age
5. Phase 2/3 Study of the Novel Vaccine Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate AIC in Ragweed-Allergic Adults
6. Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy
7. The novel inhaled corticosteroid ciclesonide is efficacious and has a favorable safety profile in adults and adolescents with severe persistent asthma
8. Omalizumab, an anti-IgE antibody, significantly reduces emergency visits in patients with severe persistent asthma: A pooled analysis
9. Improved exacerbation rates and asthma control in current and former smokers treated with salmeterol/fluticasone propionate: Results of the GOAL study
10. Early intervention with budesonide in recent onset mild persistent asthma in children: START trial results
11. Can total control of asthma be achieved? The results of the GOAL study
12. The effect of salmeterol (SAL) on the late phase response (LPR) to antigen challenge (AC), sputum eosinophilia and generation of IL-5 and IFN-gamma
13. Salmeterol/fluticasone and fluticasone alone are well tolerated over 1 year of treatment stepped-up to achieve total control: Safety results of the GOAL study
14. The effect of oral corticosteroids and high-dose combination therapy on achieving control of refractory asthma
15. Improvements in asthma outcomes following 1 year of treatment with salmeterol/fluticasone or fluticasone alone when stepped up to achieve guideline-defined total control
16. Combination of salmeterol (SAL) and fluticasone (FP) works synergistically to inhibit airway inflammation post allergen challenge
17. 387 Adhesion protein expression does not parallel nasal eosinophil (EOS) influx during persistent pollen exposure in seasonal allergic rhinitis (SAR)
18. 526 The effect of parainfluenza 3 (P-3) infection upon guinea pig (GP) basophil (BAS) and mast cell (MC) histamine release (HR)
19. 439 A comparison of once-a-day theophylline and metered-dose inhaler (MDI) albuterol (ALB) in asthma treatment
20. 252 The relationship between plasma histamine (HIS) concentrations and bronchial obstruction following antigen (AG) inhalation
21. 68. Altered granulocyte isoproterenol and H2 histamine response by in vitro influenza virus
22. 67. Increased impairment of granulocyte response to isoproterenol during use of beta adrenergic aerosols
23. 228 In vitro incubation of human leukocytes with live influenza a enhances histamine release (HR)
24. 676 A potent leukotriene D 4 (LTD 4) antagonist (MK-571) significantly reduces airway obstruction in mild to moderate asthma
25. 405 Influenza a virus enhances eosinophil (EOS) generation of superoxide (O 2−)
26. 288 The effect of rhinovirus (RV) upper respiratory infection (URI) on airway reactivity in non-allergic subjects
27. 44 Histamine (HIST) and eosinophils (EOS) in nasal lavage (NL) fluid from patients with seasonal allergic rhinitis
28. 71 Monkey dander asthma
29. 27 Detection of peanut allergens by crossed radioimmunoelectrophoresis (Crie)
30. 221 Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate (GA)
31. 48 Influenza virus (INF VIR) reduces verapamil (VER) inhibition of human neutrophil (PMN) superoxide (O 2−) production
32. 80 Enhanced basophil histamine release (HR) to concanavalin A (Con A) in asthma
33. 33 Simple daily dose theophylline (THEO) and aerosol salbutamol (SAL) in asthma treatment
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.